Correlation Between Molecular Partners and Sutro Biopharma
Can any of the company-specific risk be diversified away by investing in both Molecular Partners and Sutro Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Molecular Partners and Sutro Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Molecular Partners AG and Sutro Biopharma, you can compare the effects of market volatilities on Molecular Partners and Sutro Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Molecular Partners with a short position of Sutro Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Molecular Partners and Sutro Biopharma.
Diversification Opportunities for Molecular Partners and Sutro Biopharma
0.16 | Correlation Coefficient |
Average diversification
The 3 months correlation between Molecular and Sutro is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding Molecular Partners AG and Sutro Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sutro Biopharma and Molecular Partners is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Molecular Partners AG are associated (or correlated) with Sutro Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sutro Biopharma has no effect on the direction of Molecular Partners i.e., Molecular Partners and Sutro Biopharma go up and down completely randomly.
Pair Corralation between Molecular Partners and Sutro Biopharma
Given the investment horizon of 90 days Molecular Partners AG is expected to generate 1.6 times more return on investment than Sutro Biopharma. However, Molecular Partners is 1.6 times more volatile than Sutro Biopharma. It trades about 0.08 of its potential returns per unit of risk. Sutro Biopharma is currently generating about -0.04 per unit of risk. If you would invest 389.00 in Molecular Partners AG on September 2, 2024 and sell it today you would earn a total of 193.00 from holding Molecular Partners AG or generate 49.61% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Molecular Partners AG vs. Sutro Biopharma
Performance |
| Timeline |
| Molecular Partners |
| Sutro Biopharma |
Molecular Partners and Sutro Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Molecular Partners and Sutro Biopharma
The main advantage of trading using opposite Molecular Partners and Sutro Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Molecular Partners position performs unexpectedly, Sutro Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sutro Biopharma will offset losses from the drop in Sutro Biopharma's long position.| Molecular Partners vs. Tff Pharmaceuticals | Molecular Partners vs. Eliem Therapeutics | Molecular Partners vs. Inhibrx | Molecular Partners vs. Enliven Therapeutics |
| Sutro Biopharma vs. Tff Pharmaceuticals | Sutro Biopharma vs. Eliem Therapeutics | Sutro Biopharma vs. Inhibrx | Sutro Biopharma vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Complementary Tools
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |